miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]
OncoTargets and Therapy · 2026-04 · Volume 19 · 1-2
DOI: 10.2147/ott.s614707 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-04. Verfasst von Mingkun Han und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Han, M., Chen, L., & Wang, Y. (2026). miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]. OncoTargets and Therapy, Volume 19, 1-2. https://doi.org/10.2147/ott.s614707
Vancouver
Han M, Chen L, Wang Y. miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]. OncoTargets and Therapy. 2026;Volume 19:1-2. doi:10.2147/ott.s614707
BibTeX
@article{Han2026,
author = {Han, Mingkun and Chen, Liwei and Wang, Yang},
title = {miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--2},
doi = {10.2147/ott.s614707}
}
EUVIMED